Letters to the Editor
Type I interferon signature may influence the effect of belimumab on immunoglobulin levels, including rheumatoid factor in Sjögren’s syndrome
L. Quartuccio1, C.P. Mavragani2, A. Nezos3, S. Gandolfo4, A.G. Tzioufas5, S. De Vita6
- Department of Biological and Medical Sciences, Rheumatology Clinic, University of Udine, Italy. luca.quartuccio@asuiud.sanita.fvg.it
- Department of Physiology, School of Medicine, National and Kapodistrian University of Athens, Greece.
- Department of Physiology, School of Medicine, National and Kapodistrian University of Athens, Greece.
- Department of Biological and Medical Sciences, Rheumatology Clinic, University of Udine, Italy.
- Department of Physiology, School of Medicine, National and Kapodistrian University of Athens, Greece.
- Department of Biological and Medical Sciences, Rheumatology Clinic, University of Udine, Italy.
CER10038
2017 Vol.35, N°4
PI 0719, PF 0720
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 28281461 [PubMed]
Received: 22/10/2016
Accepted : 20/12/2016
In Press: 08/03/2017
Published: 13/07/2017
